Study: Aspirin reduces risk of death from cancer

Study shows decrease of 60 per cent risk of death in cancers of the esophagus and ten percent in the prostrata

A dose of 75 mg of aspirin substantially reduces the deaths of patients with the most common cancers, according to this British study published Tuesday in the medical journal 'Lancet'.

The study, conducted by the University of Oxford in conjunction with other academic organizations shows that aspirin can prevent a fifth of deaths from common cancers.The investigation comprised 25 000 patients, mostly from the United Kingdom.

Patients who took aspirin during the investigation declined 25 percent risk of death from cancer and a reduction of ten per cent reduction in death from other instances, compared with patients who did not take the medicine.

According to the report now published, the risk of cancer dropped 20 percent in 20 years. Analyzing tumor types separately, there was A decrease risk of death from cancer of the esophagus of 60 percent, which recorded the highest success rate. Also the risk of bowel cancer in decreased drastically, from 40 percent. The lung cancer decreased by 30 percent and 10 percent of the prostate.

Cancer of the pancreas, stomach and brain were difficult to quantify given the low number of deaths.

The experts were also unable to draw conclusions on breast cancer and ovarian cancer, for lack of data.

Until now only brings it knew aspirin cut the risk of heart attacks and strokes in those who are more predisposed, despite increasing the risk of bleeding in the stomach and intestines.

Peter Cardiff, Cardiff University epidemiologist who participated in the study, to drink a glass of milk to reduce stomach irritation.

source: